These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34009535)

  • 21. Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification.
    Schneider PM; Baldus SE; Metzger R; Kocher M; Bongartz R; Bollschweiler E; Schaefer H; Thiele J; Dienes HP; Mueller RP; Hoelscher AH
    Ann Surg; 2005 Nov; 242(5):684-92. PubMed ID: 16244542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical tumor staging of adenocarcinoma of the esophagus and esophagogastric junction.
    Turkington RC; Parkes E; Kennedy RD; Eatock MM; Harrison C; McCloskey P; Purcell C
    J Clin Oncol; 2015 Mar; 33(9):1088. PubMed ID: 25646194
    [No Abstract]   [Full Text] [Related]  

  • 23. Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours.
    Thomaschewski M; Hummel R; Petrova E; Knief J; Wellner UF; Keck T; Bausch D
    World J Gastroenterol; 2018 Apr; 24(13):1429-1439. PubMed ID: 29632424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in Gastric and Esophageal Adenocarcinoma.
    Hedner C; Borg D; Nodin B; Karnevi E; Jirström K; Eberhard J
    PLoS One; 2016; 11(2):e0148101. PubMed ID: 26844548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calculated Tumor-Associated Neutrophils Are Associated with the Tumor-Stroma Ratio and Predict a Poor Prognosis in Advanced Gastric Cancer.
    Kim EY; Abdul-Ghafar J; Chong Y; Yim K
    Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic value of tumor-infiltrating neutrophils in gastric adenocarcinoma after resection.
    Zhao JJ; Pan K; Wang W; Chen JG; Wu YH; Lv L; Li JJ; Chen YB; Wang DD; Pan QZ; Li XD; Xia JC
    PLoS One; 2012; 7(3):e33655. PubMed ID: 22442706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High Mean Corpuscular Volume Predicts Poor Outcome for Patients With Gastroesophageal Adenocarcinoma.
    Jomrich G; Hollenstein M; John M; Ristl R; Paireder M; Kristo I; Asari R; Schoppmann SF
    Ann Surg Oncol; 2019 Apr; 26(4):976-985. PubMed ID: 30706229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of microsatellite-instability in gastric and gastroesophageal junction cancer patients undergoing neoadjuvant chemotherapy.
    Haag GM; Czink E; Ahadova A; Schmidt T; Sisic L; Blank S; Heger U; Apostolidis L; Berger AK; Springfeld C; Lasitschka F; Jäger D; von Knebel Doeberitz M; Kloor M
    Int J Cancer; 2019 Apr; 144(7):1697-1703. PubMed ID: 30499151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors predicting prognosis and recurrence in patients with esophago-gastric adenocarcinoma and histopathological response with less than 10 % residual tumor.
    Ott K; Blank S; Becker K; Langer R; Weichert W; Roth W; Sisic L; Stange A; Jäger D; Büchler M; Siewert JR; Lordick F
    Langenbecks Arch Surg; 2013 Feb; 398(2):239-49. PubMed ID: 23269519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neoadjuvant therapy of adenocarcinomas of the upper gastrointestinal tract. Status of radiotherapy].
    Semrau R; Vallböhmer D; Hölscher AH; Müller RP
    Chirurg; 2009 Nov; 80(11):1035-41. PubMed ID: 19820906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Prognostic Abilities Among Preoperative Laboratory Data Indices in Patients with Resectable Gastric and Esophagogastric Junction Adenocarcinoma.
    Urabe M; Yamashita H; Watanabe T; Seto Y
    World J Surg; 2018 Jan; 42(1):185-194. PubMed ID: 28741195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lung Adenocarcinoma Cells Promote Self-Migration and Self-Invasion by Activating Neutrophils to Upregulate Notch3 Expression of Cancer Cells.
    Peng W; Sheng Y; Xiao H; Ye Y; Kwantwi LB; Cheng L; Wang Y; Xu J; Wu Q
    Front Mol Biosci; 2021; 8():762729. PubMed ID: 35118116
    [No Abstract]   [Full Text] [Related]  

  • 33. Prognostic value of CD66b positive tumor-infiltrating neutrophils in testicular germ cell tumor.
    Yamada Y; Nakagawa T; Sugihara T; Horiuchi T; Yoshizaki U; Fujimura T; Fukuhara H; Urano T; Takayama K; Inoue S; Kume H; Homma Y
    BMC Cancer; 2016 Nov; 16(1):898. PubMed ID: 27863478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of resectable esophageal and gastric (mixed adeno)neuroendocrine carcinoma: A nationwide cohort study.
    van der Veen A; Seesing MFJ; Wijnhoven BPL; de Steur WO; van Berge Henegouwen MI; Rosman C; van Sandick JW; Mook S; Haj Mohammad N; Ruurda JP; Brosens LAA; van Hillegersberg R;
    Eur J Surg Oncol; 2018 Dec; 44(12):1955-1962. PubMed ID: 30201419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Demographic and lifestyle predictors of survival in patients with esophageal or gastric cancers.
    Trivers KF; De Roos AJ; Gammon MD; Vaughan TL; Risch HA; Olshan AF; Schoenberg JB; Mayne ST; Dubrow R; Stanford JL; Abrahamson P; Rotterdam H; West AB; Fraumeni JF; Chow WH
    Clin Gastroenterol Hepatol; 2005 Mar; 3(3):225-30. PubMed ID: 15765441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histopathologic Features are more Important Prognostic Factors than Primary Tumour Location in Gastro-oesophageal Adenocarcinoma Treated with Preoperative Chemoradiation and Surgery.
    Vošmik M; Laco J; Sirák I; Dvořák J; Lochman P; Hodek M; Malá P; Rejchrt S; Repák R; Leško M; Ferko A; Ryška A; Melichar B; Petera J
    Pathol Oncol Res; 2018 Apr; 24(2):373-383. PubMed ID: 28550507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapy.
    Ott K; Rachakonda PS; Panzram B; Keller G; Lordick F; Becker K; Langer R; Buechler M; Hemminki K; Kumar R
    Ann Surg Oncol; 2011 Sep; 18(9):2688-98. PubMed ID: 21347786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neoadjuvant Therapy Improves Outcomes in Locally Advanced Signet-Ring-Cell Containing Esophagogastric Adenocarcinomas.
    Heger U; Sisic L; Nienhüser H; Blank S; Hinz U; Haag GM; Ott K; Ulrich A; Büchler MW; Schmidt T
    Ann Surg Oncol; 2018 Aug; 25(8):2418-2427. PubMed ID: 29855828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Adenocarcinoma of the esophagogastric junction: prognostic factors and results of primary surgery].
    Bösing NM; Heise JW; Goretzki PE; Sarbia M; Röher HD
    Chirurg; 2004 Nov; 75(11):1088-97. PubMed ID: 15168031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Preoperative neoadjuvant chemotherapy in esophago-cardial adenocarcinoma?].
    Geissler M
    Dtsch Med Wochenschr; 2006 Jun; 131(23):1344. PubMed ID: 16761207
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.